Novogel Insulin is known generically as Degu Menthol Bis Insulin. It is used for the treatment of type 2 diabetes and the use of it requires attention to possible adverse reactions. The drug is not to be taken orally. Degu Menthol Bi-insulin is a combination of Degu insulin, Menthol insulin, etc. It is administered locally by subcutaneous injection and is prohibited to be taken orally as well as intravenously. The drug promotes the uptake of glucose by tissues such as muscle and fat, lowers blood glucose levels, and can be used to treat type 2 diabetes in adults. The drug should be used regularly under the supervision of a clinician, and self-adjustment of the dose is prohibited. Adverse reactions such as hypoglycemic manifestations like nausea and palpitations, fat hyperplasia, itchy lumps at the injection site, etc. may occur after the use of the drug, which can be ameliorated by administering the drug at the largest main meal of the day and changing the injection site, etc. If the symptoms persist or do not resolve, timely consultation at a hospital is recommended. It is prohibited to use the drug for those who are allergic to the ingredients of Degu insulin and Mentholatum insulin. When using injection needles, attention should be paid to avoid puncture, and it is recommended to change the needles in time before using the drug to avoid contamination. The drug needs to be used under the guidance of clinicians.